Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones
A technology of methylpyridoxine and its extract, which is applied in food preparation, medical raw materials derived from ginkgo biloba, drug combination, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0066] Example 1: Ginkgo biloba extract with reduced content of 4'-O-methylpyridoxine
[0067] 1249g of the extract solution obtained according to the above preparation method was adjusted with water until the ethanol content was about 40% (w / w) and applied to 50ml (corresponding to 0.28ml per gram of dry extract) Amberlite IR-120 (strongly acidic ion exchanger) ) (Tubular column: about 2×16.5 cm; flow rate: about 8 ml / min) (step I)), followed by flushing with 200 ml of 50% ethanol (w / w). The resulting solution was concentrated on a rotary evaporator and dried in vacuum at 50°C (step m)): 179.4 g.
[0068] It can be seen from the following table that the content of 4'-O-methylpyridoxine of 0.4 ppm is achieved without basically changing the content of the components related to the efficacy.
example 2
[0071] Example 2a): Ginkgo biloba extract with reduced content of diflavonoids
[0072] 500g of the extract solution obtained according to the above preparation method was adjusted with water until the ethanol content was about 40% (w / w) and applied to 400ml (corresponding to 5.7ml per gram of dry extract) Sepabeads SP-850 (adsorbent resin) ( Column: about 4×32 cm; flow rate: about 8 ml / min) (step 1)), followed by flushing with a total of about 2 liters of 40% ethanol (w / w). 10% (259.3 g) of the resulting solution was concentrated on a rotary evaporator and freeze-dried (step m)): 6.92 g. The remaining 90% of the solution was used in Example 2b).
[0073] It can be seen from the following table that the content of diflavonoids of less than 1 ppm is achieved under the condition that the content of the ingredients related to the efficacy is basically unchanged.
example 2
[0074] Example 2b): Ginkgo biloba extract with reduced content of 4'-O-methylpyridoxine and diflavonoids
[0075] 90% (2334.1g) of the solution obtained in Example 2a) was applied to 25ml (corresponding to 0.40ml per gram of dry extract) Amberlite IR-120 (strongly acidic ion exchanger) (column: about 1.5×11cm; Flow rate: about 10ml / min) (step 1)), followed by flushing with 100ml 40% ethanol (w / w). The resulting solution was concentrated on a rotary evaporator and freeze-dried (step m)): 61.67 g.
[0076] It can be seen from the table below that the 4'-O-methylpyridoxine content of 0.4 ppm and the diflavonoid content of less than 1 ppm were achieved under the condition that the content of the components related to the efficacy was basically unchanged.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
